First Time Loading...
S

Singular Genomics Systems Inc
NASDAQ:OMIC

Watchlist Manager
Singular Genomics Systems Inc
NASDAQ:OMIC
Watchlist
Price: 0.395 USD -1.25%
Updated: May 3, 2024
Section:
 

Relative Value

The Relative Value of one OMIC stock under the Base Case scenario is 1.652 USD. Compared to the current market price of 0.395 USD, Singular Genomics Systems Inc is Undervalued by 76%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

OMIC Relative Value
Base Case
1.652 USD
Undervaluation 76%
Relative Value
Price
S
Worst Case
Base Case
Best Case

Valuation Multiples

10.1
P/S
P/S
Price to Sales
10.1
vs History
42
vs Industry
18
Median 3Y
0
Median 5Y
0
Industry
3.9
Forward
12
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-2
Median 5Y
-2
Industry
30.3
Forward
-0.3
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
-2.2
Median 5Y
-2.2
Industry
23.2
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-0.5
Median 5Y
-0.5
Industry
26.9
More Details
0.2
P/B
P/B
Price to Book Value
0.2
vs History
81
vs Industry
90
Median 3Y
0.6
Median 5Y
0.6
Industry
2.5
More Details
Negative
EV/S
EV/S
Enterprise Value to Sales
N/A
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
3.8
Forward
-55.5
More Details
245.5
EV/GP
EV/GP
Enterprise Value to Gross Profit
245.5
vs History
23
vs Industry
2
Median 3Y
0
Median 5Y
0
Industry
7.7
More Details
1.4
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
1.4
vs History
21
vs Industry
50
Median 3Y
1
Median 5Y
1
Industry
16.8
Forward
1.5
More Details
1.4
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
1.4
vs History
21
vs Industry
46
Median 3Y
1
Median 5Y
1
Industry
22
Forward
1.5
More Details
1.9
EV/OCF
EV/OCF
Enterprise Value to OCF
1.9
vs History
10
vs Industry
51
Median 3Y
1
Median 5Y
1
Industry
21.1
More Details
1.8
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
1.8
vs History
10
vs Industry
38
Median 3Y
1
Median 5Y
1
Industry
27.6
More Details
Negative
EV/IC
EV/IC
Enterprise Value to IC
N/A
vs History
vs Industry
Median 3Y
-1.1
Median 5Y
-1.1
Industry
2.4
More Details

Multiples Across Competitors

OMIC Competitors Multiples
Singular Genomics Systems Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Singular Genomics Systems Inc
NASDAQ:OMIC
29.5m USD 10.1 -0.3 1.4 1.4
US
Thermo Fisher Scientific Inc
NYSE:TMO
220.9B USD 5.2 36.8 22.8 33.4
US
Danaher Corp
NYSE:DHR
182.8B USD 4.2 22.7 16.5 20.3
CH
Lonza Group AG
SIX:LONN
37.5B CHF 5.6 57.2 19.7 28.9
KR
Samsung Biologics Co Ltd
KRX:207940
54.9T KRW 14.9 64 33.7 48.6
US
IQVIA Holdings Inc
NYSE:IQV
40.3B USD 2.7 29.7 16.3 25.1
US
Agilent Technologies Inc
NYSE:A
40.3B USD 6 32.6 26.1 31.4
US
Mettler-Toledo International Inc
NYSE:MTD
26.9B USD 7.1 34.1 23.8 26.5
US
West Pharmaceutical Services Inc
NYSE:WST
26.9B USD 9.2 47.3 32.8 39.9
IE
ICON PLC
NASDAQ:ICLR
24.9B USD 3 36.4 16.5 25.4
FR
Sartorius Stedim Biotech SA
PAR:DIM
19.2B EUR 7.2 75.5 32.4 53.2

See Also

Summary
OMIC intrinsic value, competitors valuation, and company profile.
DCF Valuation
OMIC stock valuation using Discount Cash Flow valuation method.
Relative Valuation
OMIC stock valuation using valuation multiples.
Wall Street Estimates
OMIC price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
OMIC stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 133,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.